Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.
Identifieur interne : 001959 ( PubMed/Curation ); précédent : 001958; suivant : 001960Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.
Auteurs : Ponraj Prabakaran [États-Unis] ; Zhongyu Zhu ; Xiaodong Xiao ; Arya Biragyn ; Antony S. Dimitrov ; Christopher C. Broder ; Dimiter S. DimitrovSource :
- Expert opinion on biological therapy [ 1744-7682 ] ; 2009.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Anticorps antiviraux, Anticorps monoclonaux, Coronavirus, Virus Hendra, Virus Nipah, Virus du SRAS.
- Humains.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Antibodies, Monoclonal, Antibodies, Viral.
- immunology : Coronavirus, Hendra Virus, Nipah Virus, SARS Virus.
- Humans.
Abstract
Recently, several potently neutralizing fully human monoclonal antibodies (hmAbs) targeting the severe acute respiratory syndrome-associated coronavirus (SARS CoV) S glycoprotein, and the G glycoprotein of the paramyxoviruses Hendra virus (HeV) and Nipah virus (NiV) have been discovered [corrected].
DOI: 10.1517/14712590902763755
PubMed: 19216624
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001959
Links to Exploration step
pubmed:19216624Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.</title>
<author><name sortKey="Prabakaran, Ponraj" sort="Prabakaran, Ponraj" uniqKey="Prabakaran P" first="Ponraj" last="Prabakaran">Ponraj Prabakaran</name>
<affiliation wicri:level="1"><nlm:affiliation>Protein Interactions, CCRNP, NCI-Frederick, NIH, Building 469, 150B, P.O. Box B, Miller Drive, Frederick, MD 21702 1201, USA. prabakaran.ponraj@duke.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Protein Interactions, CCRNP, NCI-Frederick, NIH, Building 469, 150B, P.O. Box B, Miller Drive, Frederick, MD 21702 1201</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhu, Zhongyu" sort="Zhu, Zhongyu" uniqKey="Zhu Z" first="Zhongyu" last="Zhu">Zhongyu Zhu</name>
</author>
<author><name sortKey="Xiao, Xiaodong" sort="Xiao, Xiaodong" uniqKey="Xiao X" first="Xiaodong" last="Xiao">Xiaodong Xiao</name>
</author>
<author><name sortKey="Biragyn, Arya" sort="Biragyn, Arya" uniqKey="Biragyn A" first="Arya" last="Biragyn">Arya Biragyn</name>
</author>
<author><name sortKey="Dimitrov, Antony S" sort="Dimitrov, Antony S" uniqKey="Dimitrov A" first="Antony S" last="Dimitrov">Antony S. Dimitrov</name>
</author>
<author><name sortKey="Broder, Christopher C" sort="Broder, Christopher C" uniqKey="Broder C" first="Christopher C" last="Broder">Christopher C. Broder</name>
</author>
<author><name sortKey="Dimitrov, Dimiter S" sort="Dimitrov, Dimiter S" uniqKey="Dimitrov D" first="Dimiter S" last="Dimitrov">Dimiter S. Dimitrov</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19216624</idno>
<idno type="pmid">19216624</idno>
<idno type="doi">10.1517/14712590902763755</idno>
<idno type="wicri:Area/PubMed/Corpus">001959</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001959</idno>
<idno type="wicri:Area/PubMed/Curation">001959</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001959</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.</title>
<author><name sortKey="Prabakaran, Ponraj" sort="Prabakaran, Ponraj" uniqKey="Prabakaran P" first="Ponraj" last="Prabakaran">Ponraj Prabakaran</name>
<affiliation wicri:level="1"><nlm:affiliation>Protein Interactions, CCRNP, NCI-Frederick, NIH, Building 469, 150B, P.O. Box B, Miller Drive, Frederick, MD 21702 1201, USA. prabakaran.ponraj@duke.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Protein Interactions, CCRNP, NCI-Frederick, NIH, Building 469, 150B, P.O. Box B, Miller Drive, Frederick, MD 21702 1201</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhu, Zhongyu" sort="Zhu, Zhongyu" uniqKey="Zhu Z" first="Zhongyu" last="Zhu">Zhongyu Zhu</name>
</author>
<author><name sortKey="Xiao, Xiaodong" sort="Xiao, Xiaodong" uniqKey="Xiao X" first="Xiaodong" last="Xiao">Xiaodong Xiao</name>
</author>
<author><name sortKey="Biragyn, Arya" sort="Biragyn, Arya" uniqKey="Biragyn A" first="Arya" last="Biragyn">Arya Biragyn</name>
</author>
<author><name sortKey="Dimitrov, Antony S" sort="Dimitrov, Antony S" uniqKey="Dimitrov A" first="Antony S" last="Dimitrov">Antony S. Dimitrov</name>
</author>
<author><name sortKey="Broder, Christopher C" sort="Broder, Christopher C" uniqKey="Broder C" first="Christopher C" last="Broder">Christopher C. Broder</name>
</author>
<author><name sortKey="Dimitrov, Dimiter S" sort="Dimitrov, Dimiter S" uniqKey="Dimitrov D" first="Dimiter S" last="Dimitrov">Dimiter S. Dimitrov</name>
</author>
</analytic>
<series><title level="j">Expert opinion on biological therapy</title>
<idno type="eISSN">1744-7682</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal (immunology)</term>
<term>Antibodies, Viral (immunology)</term>
<term>Coronavirus (immunology)</term>
<term>Hendra Virus (immunology)</term>
<term>Humans</term>
<term>Nipah Virus (immunology)</term>
<term>SARS Virus (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (immunologie)</term>
<term>Anticorps monoclonaux (immunologie)</term>
<term>Coronavirus (immunologie)</term>
<term>Humains</term>
<term>Virus Hendra (immunologie)</term>
<term>Virus Nipah (immunologie)</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Anticorps monoclonaux</term>
<term>Coronavirus</term>
<term>Virus Hendra</term>
<term>Virus Nipah</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus</term>
<term>Hendra Virus</term>
<term>Nipah Virus</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Recently, several potently neutralizing fully human monoclonal antibodies (hmAbs) targeting the severe acute respiratory syndrome-associated coronavirus (SARS CoV) S glycoprotein, and the G glycoprotein of the paramyxoviruses Hendra virus (HeV) and Nipah virus (NiV) have been discovered [corrected].</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19216624</PMID>
<DateCompleted><Year>2009</Year>
<Month>05</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>10</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-7682</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>3</Issue>
<PubDate><Year>2009</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Expert opinion on biological therapy</Title>
<ISOAbbreviation>Expert Opin Biol Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.</ArticleTitle>
<Pagination><MedlinePgn>355-68</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1517/14712590902763755 </ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recently, several potently neutralizing fully human monoclonal antibodies (hmAbs) targeting the severe acute respiratory syndrome-associated coronavirus (SARS CoV) S glycoprotein, and the G glycoprotein of the paramyxoviruses Hendra virus (HeV) and Nipah virus (NiV) have been discovered [corrected].</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine, compare and contrast the functional characteristics of hmAbs with the potential for prophylaxis and treatment of diseases caused by SARS CoV, HeV and NiV.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A review of relevant literature.</AbstractText>
<AbstractText Label="RESULTS/CONCLUSIONS" NlmCategory="CONCLUSIONS">Structural, functional and biochemical analyses [corrected] have provided insights into the molecular mechanisms of receptor recognition and antibody neutralization, and suggested that these antibodies alone or in combination could fight the viruses' heterogeneity and mutability, which is a major problem in the development of effective therapeutic agents against viruses, including therapeutic antibodies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prabakaran</LastName>
<ForeName>Ponraj</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Protein Interactions, CCRNP, NCI-Frederick, NIH, Building 469, 150B, P.O. Box B, Miller Drive, Frederick, MD 21702 1201, USA. prabakaran.ponraj@duke.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhu</LastName>
<ForeName>Zhongyu</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y"><LastName>Xiao</LastName>
<ForeName>Xiaodong</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y"><LastName>Biragyn</LastName>
<ForeName>Arya</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dimitrov</LastName>
<ForeName>Antony S</ForeName>
<Initials>AS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Broder</LastName>
<ForeName>Christopher C</ForeName>
<Initials>CC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dimitrov</LastName>
<ForeName>Dimiter S</ForeName>
<Initials>DS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>U54 AI057168-010002</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>AI057168</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01CO12400</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U54 AI057168</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U54 AI057168-05S20013</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>N01-CO-12400</GrantID>
<Acronym>CO</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Expert Opin Biol Ther</MedlineTA>
<NlmUniqueID>101125414</NlmUniqueID>
<ISSNLinking>1471-2598</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Expert Opin Biol Ther. 2009 Apr;9(4):533</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045404" MajorTopicYN="N">Hendra Virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045405" MajorTopicYN="N">Nipah Virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>117</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19216624</ArticleId>
<ArticleId IdType="doi">10.1517/14712590902763755</ArticleId>
<ArticleId IdType="pii">10.1517/14712590902763755</ArticleId>
<ArticleId IdType="pmc">PMC2705284</ArticleId>
<ArticleId IdType="mid">NIHMS93623</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Virol. 2006 Jan;80(2):891-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16378991</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AIDS. 2002 Jul 5;16(10):1391-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12131216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Lett. 2004 Sep;95(2):139-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15388253</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Struct Mol Biol. 2008 Jun;15(6):567-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18488039</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14651994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2004 Sep 1;120(1):87-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15234813</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16169905</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BioDrugs. 1998 Jun;9(6):487-507</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18020581</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 1977;55(4):435-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">304386</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Life Sci. 2004 Oct;61(19-20):2428-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15526150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2004 Aug;23(8):707-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15295219</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15210961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15530413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Immunol. 1999 Oct;93(1):5-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10497006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Neurol. 1999 Sep;46(3):428-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10482278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2004 Sep;31(1):66-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15288616</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2004 Dec 5;330(1):8-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15527829</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Jun;79(11):6690-702</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15890907</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2006 Jul;3(7):e237</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16796401</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2005 Jul 21;436(7049):401-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16007075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hong Kong Med J. 2003 Aug;9(4):309; author reply 310</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12904626</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2001 Apr;3(4):277-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11334744</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1984 Aug 4;2(8397):255-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6146809</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Hematol. 1999 May;61(1):16-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10331506</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1195-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7862660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vopr Virusol. 1997 Jul-Aug;42(4):168-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9304297</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2004 Aug;10(8):871-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15247913</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Jun 26;363(9427):2139-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 May;79(10):5900-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15857975</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hong Kong Med J. 2003 Oct;9(5):391-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14530539</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Sep 16;309(5742):1864-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16166518</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Mar 19;315(4):1134-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14985131</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Apr 1;428(6982):561-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15024391</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2000 May;2(6):701-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10884621</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2004 Dec;10(12):1062-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15606632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Apr;79(7):3962-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15767398</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AJNR Am J Neuroradiol. 2000 Mar;21(3):455-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10730635</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):179-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030680</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2001 Jul-Aug;7(4):759</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11585547</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2006 Jan;4(1):23-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16357858</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Transpl Infect Dis. 2002 Sep;4(3):160-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12421462</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 1994 Aug;38(8):1695-702</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7985997</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2008 Mar 15;197(6):846-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18271743</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunopharmacol Immunotoxicol. 1995 Feb;17(1):33-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7759773</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Transplantation. 1997 Dec 27;64(12):1847-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9422430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Natl Med Assoc. 1997 Aug;89(8):543-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9264222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Anti Infect Ther. 2006 Feb;4(1):43-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16441208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1948-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12748314</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Apr 15;174(8):4908-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15814718</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Feb;79(3):1635-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15650189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2003 May 1;36(9):e100-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12715326</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jul;78(13):6938-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194770</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9953-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18632560</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2005 Jan 4;23(7):924-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15603894</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Pharmacol Sci. 2004 Jun;25(6):306-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15165745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Feb;80(4):1972-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16439553</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15642942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2006 Jun 9;281(23):15829-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16597622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2000 May 26;288(5470):1432-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10827955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15474494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2004 Sep;2(9):695-703</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15372080</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1995 Apr 7;268(5207):94-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7701348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Nov;78(22):12672-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15507655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2004 Oct;85(Pt 10):3109-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15448374</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2006 Nov 10;281(45):34610-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16954221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2000 Apr 27;342(17):1229-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10781618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Mar;79(5):2678-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15708987</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15096611</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10652-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15998730</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2005 Jul 1;350(1):126-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15907931</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1998 Jun 18;393(6686):648-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9641677</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AIDS. 1992 Nov;6(11):1235-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1472330</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2004 Aug 15;326(1):140-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15262502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2004 Jul 1;190(1):91-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15195247</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1990 Mar 31;335(8692):791-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1969533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jun;78(12):6134-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15163706</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 1997 Jul;16(7):718-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9239781</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 1998 Apr;38(1):1-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9613999</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2000 Aug;47(2):57-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10996394</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2004 Jul 1;324(2):251-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15207612</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1999 Oct 9;354(9186):1257-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10520635</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Neurol. 2000 Nov;48(5):802-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11079547</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Jan;79(1):503-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15596843</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2005;2:73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16122388</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Dec 6;362(9399):1895-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14667748</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jan;78(2):834-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14694115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2005 Jul;11(7):1016-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16022774</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Mol Ther. 2005 Apr;7(2):151-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15844623</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2005 Mar 30;334(1):74-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15749124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 1995 Jul;21(1):150-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7578724</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 1999 Apr 30;48(16):335-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10366143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2004 Sep 15;190(6):1119-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15319862</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12123-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17620608</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Sep;79(18):11638-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16140741</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2007 Feb 15;445(7129):732-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17301785</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1989 Aug 24;321(8):519-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2548098</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Immunol. 2005 Jan;42(1):125-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15488951</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2000 May;181(5):1760-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10823780</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Investig. 1994 Feb;72(3):220-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7912123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2004 Sep 15;173(6):4050-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15356154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2004 Feb;2(2):109-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15043007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>DNA Cell Biol. 2004 Jun;23(6):391-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15231072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2007 Jun;142(1-2):29-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17292974</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2003 Feb 1;187(3):500-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12552435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Jun 26;363(9427):2122-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220033</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2005 Feb 15;191(4):507-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655773</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jul;78(13):7217-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int Immunol. 2004 Oct;16(10):1423-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15314040</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Apr;78(7):3572-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15016880</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2005 Jul 22;333(1):186-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15939399</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001959 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001959 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:19216624 |texte= Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19216624" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |